Cilnidipine is a calcium channel blocker compound used as an active pharmaceutical ingredient. It is notably approved for use in Japan, China, India, Nepal, and Korea for the management of hypertension.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 132203-70-4
Pranidipine
pharmaceutical raw material
Captamine hydrochloride
pharmaceutical raw material
Olanzapine
pharmaceutical raw material
Tulobuterol-d9 Hydrochloride
pharmaceutical raw material
Emoxypine hydrochloride
pharmaceutical raw material
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrosophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
research compound
3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
KJEBULYHNRNJTE-DHZHZOJOSA-N
CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC